Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan aldeyra.com (ALDX)

Simbol resmi perusahaan Aldeyra Therapeutics, Inc. (ALDX)

Aldeyra Therapeutics (ALDX) is competing for the ophthalmology market, where access is restricted by patents on anti-inflammatory molecules. This quarterly earnings per share chart demonstrates the asset's dynamics, while 51.10 reflects the metric's latest value. Growth depends on FDA approval of reproxalap and new developments. Currently, commercialization is blocked pending the regulator's final verdict, despite investor interest.

Aldeyra Therapeutics, Inc. (ALDX) - Wutah bathi EPS kuartalan saka 04.07.2022 nganti 16.11.2026

Rincian metrik komprehensif lan analitis aldeyra.com (ALDX)

- rega saham lan prakiraan rega para ahli:
Analisis komprehensif perusahaan:Aldeyra Therapeutics Inc., ALDX
Barang unggulan Aldeyra Therapeutics

Earnings per share dynamics determine the fundamental stability of the business over the long term. This metric captures the percentage change in quarterly net income, stripping the financial result of market volatility. By assessing quarterly EPS growth, an investor tracks the pace of asset capitalization. For Aldeyra Therapeutics (ALDX), this indicator reflects the efficiency of implementing automated molecule screening systems. The robotization of ophthalmological research should convert into lower costs and increased bottom-line profit.

Analisis perusahaan pesaing

Alcon Corp (ALC) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Bausch Health (BLCO)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan glaukos.com|Apellis Pharmaceuticals (APLS) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan BLTE|OCUL - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan HROW (Harrow Inc)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Viridian Corp (VRDN)|LENZ - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Oculis - Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|EyePoint Pharmaceuticals (EYPT) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Kodiak Sciences Inc (KOD) - Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan KALA|IRD - Wutah bathi resik saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan okyopharma.com (OKYO)|Wutah bathi EPS kuartalan Adverum Biotechnologies Inc. (ADVM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan outlooktherapeutics.com OTLK|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Clearside Biomedical, Inc. (CLSD)|NBY - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan KPRX (kiorapharma.com)|Alimera Sciences (ALIM) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Eyenovia Inc. - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|GHSI (Guardion Health Sciences) - Wutah bathi EPS kuartalan|Ocuphire Pharma - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan OPT (Opthea)